FATE OF ETIPROSTON, A SYNTHETIC ANALOG OF PGF(2-ALPHA) IN COWS

被引:0
|
作者
BENECH, H
BRUNE, P
PRUVOST, A
ARCHIMBAULT, P
GUILLOT, P
MURPHY, RC
MACLOUF, J
GROGNET, JM
机构
[1] CE SACLAY,CEA,SERV PHARMACOL & IMMUNOL,F-91191 GIF SUR YVETTE,FRANCE
[2] LAB VIRBAC,F-06511 CARROS,FRANCE
[3] CTR NATL ETUD VET & ALIMENTAIRES,MEDICAMENTS VET LAB,F-35133 FOUGERES,FRANCE
[4] NATL JEWISH CTR IMMUNOL & RESP MED,DENVER,CO 80206
[5] HOP LARIBOISIERE,INSERM,U150,F-75475 PARIS 10,FRANCE
关键词
D O I
10.1111/j.1365-2885.1994.tb00256.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The pharmacokinetics and metabolic fate of labelled compounds were investigated after intramuscular administration of H-3-radiolabelled etiproston to nine cows. Elimination was rapid (t1/2beta = 2.8 h). Forty-eight h after administration 92.6% of the radioactivity had been eliminated, mainly via the urinary (66% at 48 h) and faecal routes (26% at 48 h). In comparison, little elimination in milk occurred (less than 0.034% dose/l by 24 h). Radioactivity at the injection site 48 h after administration was seen in one cow (< 4.68 x 10(-5)% dose/g). No radioactivity was detected in the tissues. Urinary metabolites were purified and isolated using XAD-2 extraction and preparative HPLC in reverse and normal phases. The main urinary metabolite, identified by mass spectrometry, was the tetranor acid derivative in equilibrium with its lactone form.
引用
收藏
页码:339 / 344
页数:6
相关论文
共 50 条